FDA Approved: SARCLISA — Original Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

The FDA approved Sarclisa (isatuximab) in its original application for adult patients with relapsed or refractory multiple myeloma, in combination with pomalido…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• SARCLISA (isatuximab)

Snippet

ORIG AP for SARCLISA (ISATUXIMAB)